Status:
TERMINATED
Open Label Study of Duloxetine for the Treatment of Phantom Limb Pain
Lead Sponsor:
Baylor College of Medicine
Conditions:
Chronic Phantom Limb Pain
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This is a study to assess the possible benefit of duloxetine in the treatment of chronic phantom limb pain.
Eligibility Criteria
Inclusion
- Chronic PLP \> 6 months
- Short-Form McGill Pain Questionnaire Sensory Pain Rating Index raw score ≥ 16
- Age ≥ 18 years old
- Inpatient or Outpatient
- Able to come to all appointments, in the opinion of the investigator
- Able to give informed consent, in opinion of investigator
Exclusion
- Current Major Depressive disorder, Anxiety Disorder, or Psychotic disorder assessed by the Mini International Neuropsychiatric Interview (MINI)
- Substance abuse or dependence within the last six months, as assessed by the MINI
- Known Diabetes Mellitus to exclude diabetic peripheral neuropathy
- History of coronary artery disease, hepatic disease, renal disease
- Other pain syndromes
- Any unstable medical conditions in the opinion of the investigator
- Other psychotropic medications excluding hypnotics
Key Trial Info
Start Date :
January 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2007
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT00425230
Start Date
January 1 2007
End Date
June 1 2007
Last Update
August 12 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Micheal E. DeBakey Veterans Hospital
Houston, Texas, United States, 77030